Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma

Authors:
  • APAlberto Papi
    Alberto Papi
  • BCBradley E. Chipps
    Bradley E. Chipps
  • RPReynold A. Panettieri
    Reynold A. Panettieri
  • EIElliot Israel
    Elliot Israel
  • MCMark Cooper
    Mark Cooper
  • LDLynn Dunsire
    Lynn Dunsire
  • AJAllison Jeynes-Ellis
    Allison Jeynes-Ellis
  • EJEva Johnsson
    Eva Johnsson
  • RRRobert Rees
    Robert Rees
  • CCChristy Cappelletti
    Christy Cappelletti

Abstract
As asthma symptoms worsen, patients typically rely on short-acting β2-agonist (SABA) rescue therapy, but SABAs do not address worsening inflammation, which leaves patients at risk for severe asthma exacerbations. The use of a fixed-dose combination of albuterol and budesonide, as compared with albuterol alone, as rescue medication might reduce the risk of severe asthma exacerbation.
Funding Information
  • Avillion LLP

This publication has 30 references indexed in Scilit: